Table of Contents

1 Study Coverage

• 1.1 Breast Cancer Screening Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Breast Cancer Screening Market Size Growth Rate by Product
  • 1.4.2 Mammography Screening
  • 1.4.3 Breast Magnetic Resonance Imaging (MRI) Screening
  • 1.4.4 Breast Ultrasound Screening
• 1.5 Market by End User
  • 1.5.1 Global Breast Cancer Screening Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Clinic
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Breast Cancer Screening Market Size
  • 2.1.1 Global Breast Cancer Screening Revenue 2014-2025
  • 2.1.2 Global Breast Cancer Screening Sales 2014-2025
• 2.2 Breast Cancer Screening Growth Rate by Regions
  • 2.2.1 Global Breast Cancer Screening Sales by Regions
  • 2.2.2 Global Breast Cancer Screening Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Breast Cancer Screening Sales by Manufacturers
  • 3.1.1 Breast Cancer Screening Sales by Manufacturers
  • 3.1.2 Breast Cancer Screening Sales Market Share by Manufacturers
  • 3.1.3 Global Breast Cancer Screening Market Concentration Ratio (CR5 and HHI)
• 3.2 Breast Cancer Screening Revenue by Manufacturers
  • 3.2.1 Breast Cancer Screening Revenue by Manufacturers (2014-2019)
  • 3.2.2 Breast Cancer Screening Revenue Share by Manufacturers (2014-2019)
• 3.3 Breast Cancer Screening Price by Manufacturers
• 3.4 Breast Cancer Screening Manufacturing Base Distribution, Product Types
  • 3.4.1 Breast Cancer Screening Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Breast Cancer Screening Product Type
  • 3.4.3 Date of International Manufacturers Enter into Breast Cancer Screening Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Breast Cancer Screening Sales by Product
• 4.2 Global Breast Cancer Screening Revenue by Product
• 4.3 Breast Cancer Screening Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Breast Cancer Screening Breakdown Data by End User

6 North America

• 6.1 North America Breast Cancer Screening by Countries
  • 6.1.1 North America Breast Cancer Screening Sales by Countries
  • 6.1.2 North America Breast Cancer Screening Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Breast Cancer Screening by Product
• 6.3 North America Breast Cancer Screening by End User

7 Europe

• 7.1 Europe Breast Cancer Screening by Countries
  • 7.1.1 Europe Breast Cancer Screening Sales by Countries
  • 7.1.2 Europe Breast Cancer Screening Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Breast Cancer Screening by Product
• 7.3 Europe Breast Cancer Screening by End User

8 Asia Pacific

• 8.1 Asia Pacific Breast Cancer Screening by Countries
  • 8.1.1 Asia Pacific Breast Cancer Screening Sales by Countries
  • 8.1.2 Asia Pacific Breast Cancer Screening Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Breast Cancer Screening by Product
• 8.3 Asia Pacific Breast Cancer Screening by End User

9 Central & South America

• 9.1 Central & South America Breast Cancer Screening by Countries
  • 9.1.1 Central & South America Breast Cancer Screening Sales by Countries
  • 9.1.2 Central & South America Breast Cancer Screening Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Breast Cancer Screening by Product
• 9.3 Central & South America Breast Cancer Screening by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Breast Cancer Screening by Countries
  • 10.1.1 Middle East and Africa Breast Cancer Screening Sales by Countries
  • 10.1.2 Middle East and Africa Breast Cancer Screening Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Breast Cancer Screening by Product
• 10.3 Middle East and Africa Breast Cancer Screening by End User

11 Company Profiles

• 11.1 Hologic
  • 11.1.1 Hologic Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Hologic Breast Cancer Screening Products Offered
  • 11.1.5 Hologic Recent Development
• 11.2 GE Healthcare
  • 11.2.1 GE Healthcare Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 GE Healthcare Breast Cancer Screening Products Offered
  • 11.2.5 GE Healthcare Recent Development
• 11.3 Siemen Healthineers
  • 11.3.1 Siemen Healthineers Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Siemen Healthineers Breast Cancer Screening Products Offered
  • 11.3.5 Siemen Healthineers Recent Development
• 11.4 Philips Healthcare
  • 11.4.1 Philips Healthcare Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Philips Healthcare Breast Cancer Screening Products Offered
  • 11.4.5 Philips Healthcare Recent Development
• 11.5 Canon Medical
  • 11.5.1 Canon Medical Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Canon Medical Breast Cancer Screening Products Offered
  • 11.5.5 Canon Medical Recent Development
• 11.6 Fujifilm
  • 11.6.1 Fujifilm Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Fujifilm Breast Cancer Screening Products Offered
  • 11.6.5 Fujifilm Recent Development
• 11.7 Metaltronica
  • 11.7.1 Metaltronica Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Metaltronica Breast Cancer Screening Products Offered
  • 11.7.5 Metaltronica Recent Development
• 11.8 Sino Medical-Device
  • 11.8.1 Sino Medical-Device Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Sino Medical-Device Breast Cancer Screening Products Offered
  • 11.8.5 Sino Medical-Device Recent Development
• 11.9 IMS Srl
  • 11.9.1 IMS Srl Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 IMS Srl Breast Cancer Screening Products Offered
  • 11.9.5 IMS Srl Recent Development

12 Future Forecast

• 12.1 Breast Cancer Screening Market Forecast by Regions
  • 12.1.1 Global Breast Cancer Screening Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Breast Cancer Screening Revenue Forecast by Regions 2019-2025
• 12.2 Breast Cancer Screening Market Forecast by Product
  • 12.2.1 Global Breast Cancer Screening Sales Forecast by Product 2019-2025
  • 12.2.2 Global Breast Cancer Screening Revenue Forecast by Product 2019-2025
• 12.3 Breast Cancer Screening Market Forecast by End User
• 12.4 North America Breast Cancer Screening Forecast
• 12.5 Europe Breast Cancer Screening Forecast
• 12.6 Asia Pacific Breast Cancer Screening Forecast
• 12.7 Central & South America Breast Cancer Screening Forecast
• 12.8 Middle East and Africa Breast Cancer Screening Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Breast Cancer Screening Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
The top players cover Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare and GE Healthcare etc., which are playing important roles in global Breast Cancer Screening market.
At present, global economy is fluctuant, and most countries take measures to stimulate the economy, especially in Rest of Asia, Europe, Australia and the resources providing countries, like Russia, Middle East, Brazil etc. In many fields, China is the largest consumer, but in the past several years, China's economic growth slows. The China government is reforming the economic structure, to release energy of economy. USA economy is relatively stable with low-speed-growth, but in future, it also is full of risk. In Southeast Asia, the economy also is fluctuated the economic base is comparatively unsubstantial, due to the exchange fluctuations. In India, although many people look to further increase in India, but the economic aggregate is too low and the infrastructure is behindhand and inefficient. In a long term, India will keep a stable and low growth in economy, due to its economic structure and bureaucratic system.
On the other hand, the political factors, like government succession, security fears, trade dispute, domestic employment, even the regional military crisis, always affect the economic activity, country to country, corporation to country. So it needs us with deep insight, to analyze the prospect avoid risk, to grasp the opportunity and reduce losses.
The global Breast Cancer Screening market is valued at 1430 million US$ in 2018 and will reach 2710 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Breast Cancer Screening market based on company, product type, end user and key regions.

This report studies the global market size of Breast Cancer Screening in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Breast Cancer Screening in these regions.
This research report categorizes the global Breast Cancer Screening market by top players/brands, region, type and end user. This report also studies the global Breast Cancer Screening market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl

Market size by Product
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Market size by End User
Hospital
Clinic

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Breast Cancer Screening market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Breast Cancer Screening market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Breast Cancer Screening companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Breast Cancer Screening submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Breast Cancer Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Breast Cancer Screening market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.